Pflug Koory’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Hold
1,857
0.09% 149
2026
Q1
$259K Sell
1,857
-105
-5% -$14.7K 0.12% 140
2025
Q4
$241K Hold
1,962
0.11% 146
2025
Q3
$218K Hold
1,962
0.1% 150
2025
Q2
$218K Hold
1,962
0.11% 145
2025
Q1
$220K Sell
1,962
-181
-8% -$18.7K 0.12% 143
2024
Q4
$198K Buy
2,143
+150
+8% +$13.5K 0.1% 151
2024
Q3
$167K Buy
+1,993
New +$152K 0.08% 161
2024
Q1
$148K Sell
2,020
-5
-0.2% -$384 0.07% 169
2023
Q4
$164K Hold
2,025
0.09% 159
2023
Q3
$152K Hold
2,025
0.09% 158
2023
Q2
$156K Hold
2,025
0.08% 169
2023
Q1
$168K Sell
2,025
-100
-5% -$8.28K 0.09% 158
2022
Q4
$182K Sell
2,125
-95
-4% -$7.52K 0.1% 153
2022
Q3
$137K Hold
2,220
0.08% 170
2022
Q2
$137K Sell
2,220
-100
-4% -$6.19K 0.08% 174
2022
Q1
$138K Sell
2,320
-375
-14% -$24K 0.07% 185
2021
Q4
$196K Hold
2,695
0.1% 163
2021
Q3
$188K Sell
2,695
-500
-16% -$35.1K 0.1% 162
2021
Q2
$220K Buy
3,195
+500
+19% +$33.4K 0.12% 160
2021
Q1
$174K Sell
2,695
-638
-19% -$41.1K 0.1% 168
2020
Q4
$194K Sell
3,333
-490
-13% -$29.6K 0.11% 163
2020
Q3
$242K Buy
3,823
+250
+7% +$17.3K 0.16% 126
2020
Q2
$275K Hold
3,573
0.2% 111
2020
Q1
$267K Hold
3,573
0.24% 102
2019
Q4
$232K Buy
3,573
+25
+0.7% +$1.63K 0.16% 136
2019
Q3
$225K Buy
3,548
+65
+2% +$4.25K 0.17% 136
2019
Q2
$235K Sell
3,483
-260
-7% -$17.1K 0.18% 131
2019
Q1
$243K Sell
3,743
-125
-3% -$8.31K 0.19% 129
2018
Q4
$242K Sell
3,868
-1,250
-24% -$87.4K 0.21% 118
2018
Q3
$395K Sell
5,118
-280
-5% -$21.1K 0.32% 93
2018
Q2
$382K Hold
5,398
0.3% 96
2018
Q1
$407K Sell
5,398
-100
-2% -$7.95K 0.34% 91
2017
Q4
$394K Hold
5,498
0.31% 105
2017
Q3
$445K Buy
5,498
+150
+3% +$11.5K 0.36% 89
2017
Q2
$379K Buy
5,348
+415
+8% +$27.6K 0.32% 94
2017
Q1
$335K Buy
4,933
+875
+22% +$61.5K 0.29% 101
2016
Q4
$291 Buy
+4,058
New +$302K 0.25% 109

Other funds holding GILD

Pflug Koory's GILD Position: Q2 2026 in Review

Pflug Koory held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,857 shares worth $235K. The position accounts for 0.09% of the portfolio, ranked #149.

Pflug Koory first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. The position peaked at $445K in Q3 2017. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pflug Koory held 1,857 shares of Gilead Sciences worth $235K as of Q2 2026.
  • Pflug Koory left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.09% of Pflug Koory's portfolio in Q2 2026, its #149 holding.
  • Pflug Koory first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
  • Pflug Koory's Gilead Sciences position peaked at $445K in Q3 2017.
  • 485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.